Warning: fopen(/home/d4257/public_html/wordpress/wp-content/wflogs/rules.php) [function.fopen]: failed to open stream: No such file or directory in /home/d4257/public_html/wordpress/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/waf.php on line 325

Warning: flock() expects parameter 1 to be resource, boolean given in /home/d4257/public_html/wordpress/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/waf.php on line 326

Warning: include(/home/d4257/public_html/wordpress/wp-content/wflogs/rules.php) [function.include]: failed to open stream: No such file or directory in /home/d4257/public_html/wordpress/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/waf.php on line 328

Warning: include(/home/d4257/public_html/wordpress/wp-content/wflogs/rules.php) [function.include]: failed to open stream: No such file or directory in /home/d4257/public_html/wordpress/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/waf.php on line 328

Warning: include() [function.include]: Failed opening '/home/d4257/public_html/wordpress/wp-content/wflogs/rules.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/d4257/public_html/wordpress/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/waf.php on line 328

Warning: flock() expects parameter 1 to be resource, boolean given in /home/d4257/public_html/wordpress/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/waf.php on line 329

Warning: fclose() expects parameter 1 to be resource, boolean given in /home/d4257/public_html/wordpress/wp-content/plugins/wordfence/vendor/wordfence/wf-waf/src/lib/waf.php on line 330

Warning: rename(/home/d4257/public_html/wordpress/wp-content/cache/wpscvkisA6.php,/home/d4257/public_html/wordpress/wp-content/wp-cache-config.php) [function.rename]: Permission denied in /home/d4257/public_html/wordpress/wp-content/plugins/wp-super-cache/wp-cache-phase2.php on line 1263
Trial in Alzheimers disease | Apodemus AB

Trial in Alzheimers disease

Apodemus is currently performing a phase IIa trial in Alzheimers disease. The main part of the trial has been completed whereas the follow-up part is scheduled to end in June 2016. The results from the main part of the trial have been analysed. The outcome of the trial has been found to be inconclusive due to a large drop-out rate that made data difficult to interpret. In order to test the hypothesis properly Apodemus AB will assess whether to repeat the trial with a modification of its design. A decision to continue development or not will be taken shortly.